|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
1
|
|
pubmed:dateCreated |
2004-12-15
|
|
pubmed:abstractText |
We designed a dose- and time-intensified high-dose sequential chemotherapy regimen for patients with relapsed and refractory Hodgkin lymphoma (HD).
|
|
pubmed:commentsCorrections |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Antineoplastic Agents, Alkylating,
http://linkedlifedata.com/resource/pubmed/chemical/Carmustine,
http://linkedlifedata.com/resource/pubmed/chemical/Cisplatin,
http://linkedlifedata.com/resource/pubmed/chemical/Cyclophosphamide,
http://linkedlifedata.com/resource/pubmed/chemical/Cytarabine,
http://linkedlifedata.com/resource/pubmed/chemical/Dexamethasone,
http://linkedlifedata.com/resource/pubmed/chemical/Etoposide,
http://linkedlifedata.com/resource/pubmed/chemical/Granulocyte Colony-Stimulating...,
http://linkedlifedata.com/resource/pubmed/chemical/Melphalan,
http://linkedlifedata.com/resource/pubmed/chemical/Methotrexate,
http://linkedlifedata.com/resource/pubmed/chemical/Vincristine
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jan
|
|
pubmed:issn |
0923-7534
|
|
pubmed:author |
pubmed-author:BerdelW EWE,
pubmed-author:DörkenBB,
pubmed-author:DiehlVV,
pubmed-author:EngertAA,
pubmed-author:GlossmannJ-PJP,
pubmed-author:HossfeldD KDK,
pubmed-author:JostingAA,
pubmed-author:KirchnerH HHH,
pubmed-author:KisroJJ,
pubmed-author:MaparaMM,
pubmed-author:MetznerBB,
pubmed-author:RudolphCC,
pubmed-author:SieberMM,
pubmed-author:SienawskiMM,
pubmed-author:SieniawskiMM
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
16
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
116-23
|
|
pubmed:dateRevised |
2008-8-22
|
|
pubmed:meshHeading |
pubmed-meshheading:15598948-Adolescent,
pubmed-meshheading:15598948-Adult,
pubmed-meshheading:15598948-Antineoplastic Agents, Alkylating,
pubmed-meshheading:15598948-Antineoplastic Combined Chemotherapy Protocols,
pubmed-meshheading:15598948-Carmustine,
pubmed-meshheading:15598948-Cisplatin,
pubmed-meshheading:15598948-Combined Modality Therapy,
pubmed-meshheading:15598948-Cyclophosphamide,
pubmed-meshheading:15598948-Cytarabine,
pubmed-meshheading:15598948-Dexamethasone,
pubmed-meshheading:15598948-Disease-Free Survival,
pubmed-meshheading:15598948-Dose-Response Relationship, Drug,
pubmed-meshheading:15598948-Etoposide,
pubmed-meshheading:15598948-Female,
pubmed-meshheading:15598948-Granulocyte Colony-Stimulating Factor,
pubmed-meshheading:15598948-Hodgkin Disease,
pubmed-meshheading:15598948-Humans,
pubmed-meshheading:15598948-Infusions, Intravenous,
pubmed-meshheading:15598948-Injections, Subcutaneous,
pubmed-meshheading:15598948-Male,
pubmed-meshheading:15598948-Melphalan,
pubmed-meshheading:15598948-Methotrexate,
pubmed-meshheading:15598948-Middle Aged,
pubmed-meshheading:15598948-Peripheral Blood Stem Cell Transplantation,
pubmed-meshheading:15598948-Recurrence,
pubmed-meshheading:15598948-Treatment Outcome,
pubmed-meshheading:15598948-Vincristine
|
|
pubmed:year |
2005
|
|
pubmed:articleTitle |
Cologne high-dose sequential chemotherapy in relapsed and refractory Hodgkin lymphoma: results of a large multicenter study of the German Hodgkin Lymphoma Study Group (GHSG).
|
|
pubmed:affiliation |
First Department of Internal Medicine, University Hospital Cologne, Germany. andreas.josting@uni-koeln.de
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Multicenter Study,
Clinical Trial, Phase II
|
